CARDIOVASCULAR
hamburger
product photo
EXCELLENT RESULTS ACROSS THE WIDEST RANGE OF APPLICATIONS

The CentriMag™ Circulatory Support System with Full MagLev™ flow technology offers excellent hemocompatibility and unparalleled versatility for optimized patient care.

THIS DEVICE IS COMMERCIALLY AVAILABLE FOR USE IN SELECT INTERNATIONAL MARKETS

Driven by Full MagLev™ flow technology, the CentriMag pump includes a free-floating magnetically levitated rotor for a contact-free environment. This innovative technology results in excellent hemodynamics, which can lead to minimized blood stagnation, friction and shear stress.3,4

FULL MAGLEV™ FLOW TECHNOLOGY: DESIGNED FOR OPTIMAL HEMOCOMPATIBILITY1,2

See the CentriMag™ pump’s Full MagLev™ flow technology in action, with electromagnetic forces controlling a levitated rotor for precise control of rotational speed.

play video

The system helps you provide optimal patient care for a broad range of clinical applications:5 biventricular assist device (BIVAD), left ventricular assist device (LVAD), right ventricular assist device (RVAD), extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS), wean/bridge to recovery, bridge to decision, bridge to durable ventricular assist device (VAD), bridge to transplantation.

 

diagram of the application wheel for Centrimag

 

The CentriMag Circulatory Support System produces flows up to 9.9 LPM with fewer rotations per minute6 to help minimize blood trauma while still providing optimal flow support.7

 

graphic of different sizes of people
DESIGNED TO MEET INDIVIDUALIZED REQUIREMENTS
What You Need

Giving you freedom of choice, the CentriMag System:

  • Fits seamlessly into custom circuit designs to easily adapt to clinician preferences
  • Can be used with a variety of cannulation options
Where You Need It
  • The CentriMag System is fully transportable via air or ground ambulance using the compact system transporter.
  • The transporter complies with all prevailing standards for air and ground transportation.
BUILDING COMPREHENSIVE HEART FAILURE MANAGEMENT

The CentriMag™ Circulatory Support System is part of our heart failure management portfolio. Read more about our approach to heart failure management.

REFERENCES

1. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085
2. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939.http://dx.doi.org/10.1016/j.jtcvs.2010.03.046 
3. Aziz, T. A., Singh, G., Popjes, E., Stephenson, E., Mulvey, S., Pae, W., & El-Banayosy, A. (2010). Initial experience with CentriMag extracorporeal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. The Journal of Heart and Lung Transplantation, 29(1), 66-71.http://dx.doi.org/10.1016/j.healun.2009.08.025 
4. Borisenko, O., Wylie, G., Payne, J., Bjessmo, D., Smith, J., Yonan, N. & Firmin, R. (2014). Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or sever cardiopulmonary insufficiency: A systematic literature review and meta-analysis of observational studies. American Society for Artificial Internal Organs Journal, 60, 487-497.http://dx.doi.org/10.1097/MAT.0000000000000117
5. Bhama, J. K., Kornos, R. L., Toyoda, Y., Teuteberg, J. J., McCurry, K. R., & Siegenthaler, M. P. (2009). Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. The Journal of Heart and Lung Transformation, 28(9), 971-976.http://dx.doi/org/10.1016/j.healun.2009.04.015
6. De Robertis, F., Briks, E. J., Dreyfus, G., Pepper, J. R., & Khaghani, A. (2006). Clinical performance with the Levitonix CentriMag short-term ventricular assist device. The Journal and Heart and Lung Transplantation, 25(2), 181-186. http://dx.doi.org/10.1016/j.healun.2005.08.019
7. Zhang, J., Gellman, B., Koert, K. A., Gilbert, R. J., Griffith, B. P., & Wu, Z. J. (2006). Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artificial Organs, 30(3), 168-177. http://dx.doi.org/10.1111/j.1525-1594.2006.00203

FULL MAGLEV™ FLOW TECHNOLOGY: EASY ON THE BLOOD

Designed for optimal hemocompatibility,1,2 Full MagLev flow technology can result in low hemolysis,1 low device-related thrombosis.1,2 and improved end-organ function.2

graphic displaying five percent low haemolysis
graphic displaying two point five percent low device-related thrombosis
REDUCED BLOOD TRAUMA,3 MINIMIZED TURBULENCE, MAINTAINED STABILITY

Providing a contact-free environment, Full MagLev technology features:

  • free-floating magnetically levitated rotor prevents surface-to-surface contact that could cause blood trauma
  • Wide blood-flow pathways and absence of seals, bearings and valves minimize blood turbulence and stasis
  • Automatic rotor positioning adjusts 50,000 times per second to maintain stable and consistent blood flow

 

graphic displaying the magnetic rotor
REFERENCES

1. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. http://dx.doi.org/10.1016/j.jtcvs.2010.03.046

2. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, L. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085

CUSTOMER
SERVICE

Our customer service experts can help with your
product orders or questions

a natural wonder of sandstone caves

OUR PRODUCTS

See our featured innovations and technologies, full product catalog and approach to disease state management.

SJM-CV WEB-0718-0035b

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?